7-Oxoprasterone - HumaneticsAlternative Names: 7-Keto DHEA; 7-Keto-dehydroepiandrosterone; At-EASE; HBL 9001; HL-9001
Latest Information Update: 03 Mar 2016
At a glance
- Originator Humanetics Corporation
- Class Obesity therapies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Post-traumatic stress disorders